Showing results (41-50 of 241) with videos related to
Sort By:
Pageof 25
Acta Diabetologica|August 6, 2000
Intensive insulin therapy combined with metformin in obese type 2 diabetic patientsA Fritsche, R M Schmülling, H U Häring, et al.Biochemical and Biophysical Research Communications|January 15, 1991
Activation of phosphatidylinositol-3-kinase by insulin is mediated by both A and B human insulin receptor typesJ M Carrascosa, B Vogt, A Ullrich, et al.Diabetologia|February 12, 1998
A 973 valine to methionine mutation of the human insulin receptor: interaction with insulin-receptor substrate-1 and Shc in HEK 293 cellsV Strack, B Bossenmaier, B Stoyanov, et al.Diabetologia|July 1, 1997
Protein kinase C isoforms beta 1 and beta 2 inhibit the tyrosine kinase activity of the insulin receptorB Bossenmaier, L Mosthaf, H Mischak, et al.Diabetes Care|May 20, 1998
Evaluation of the insertion/deletion ACE gene polymorphism as a risk factor for carotid artery intima-media thickening and hypertension in young type 1 diabetic patientsD Frost, M Pfohl, P Clemens, et al.Biomedical Chromatography : BMC|July 1, 1998
Advantages in the analysis of UDP-sugars by capillary electrophoresis-comparison of the conventional HPLC method with two new capillary electrophoretic micro-proceduresG Xu, R Lehmann, E Schleicher, et al.The Biochemical Journal|March 15, 1990
Mannose, glucosamine and inositol monophosphate inhibit the effects of insulin on lipogenesis. Further evidence for a role for inositol phosphate-oligosaccharides in insulin actionF Machicao, J Mushack, E Seffer, et al.Fertility and Sterility|February 1, 1993
Tyrosine kinase activity of insulin-like growth factor I and insulin receptors in human endometrium during the menstrual cycle: cyclic variation of insulin receptor expressionT Strowitzki, H C von Eye, M Kellerer, et al.The American Journal of Physiology|June 1, 1992
Insulin-like growth factor I-dependent tyrosine kinase activity in stromal cells of human endometrium in vitroH Von Eye Corleta, T Strowitzki, M Kellerer, et al.European Journal of Clinical Nutrition|November 14, 2013
Plasminogen activator inhibitor-1, monocyte chemoattractant protein-1, e-selectin and C-reactive protein levels in response to 4-week very-high-fructose or -glucose dietsG Silbernagel, J Machann, H-U Häring, et al.Pageof 25